AndrosteroneTMS
Compound with spectra: 3 MS (GC)
| SpectraBase Compound ID | Ige5bSCf810 |
|---|---|
| InChI | InChI=1S/C22H38O2Si/c1-21-12-10-16(24-25(3,4)5)14-15(21)6-7-17-18-8-9-20(23)22(18,2)13-11-19(17)21/h15-19H,6-14H2,1-5H3/t15-,16+,17-,18-,19-,21-,22-/m0/s1 |
| InChIKey | RKALSSDGCWGKHQ-VQZJJIPLSA-N |
| Mol Weight | 362.6 g/mol |
| Molecular Formula | C22H38O2Si |
| Exact Mass | 362.264107 g/mol |
| Enantiomer InChIKey | RKALSSDGCWGKHQ-VENWGGTKSA-N |
| Copyright | Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
| Copyright | Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
| Copyright | Copyright © 2011-2024 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Dr. Makin, London Hospital Medical College, UK |
- 5.ALPHA.-ANDROSTAN-3.ALPHA.-OL-17-ONE-TRIMETHYLSILYL ETHER
- 3-[(Trimethylsilyl)oxy]androstan-17-one
- (3aS,3bR,5aS,7R,9aS,9bS,11aS)-9a,11a-dimethyl-7-((trimethylsilyl)oxy)hexadecahydro-1H-\rcyclopenta[a]phenanthren-1-one
- (3R,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-3-(trimethylsilyloxy)tetradecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one
Androstan-17-one, 3-[[dimethyl(1-methylethyl)silyl]oxy]-, (3.alpha.,5.beta.)-
Androstan-17-one, 3-[(ethenyldimethylsilyl)oxy]-, (3.beta.,5.beta.)-
(3S,5S,8R,9S,10S,13S,14S)-3-[tert-butyl(dimethyl)silyl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
Androstan-17-one, 3-[(tripropylsilyl)oxy]-, (3.alpha.,5.alpha.)-
3-[(Tripropylsilyl)oxy]androstan-17-one
Epiandrosterone dimethylsilyl ether
Androstan-17-one, 3-(methoxymethoxy)-, (3.alpha.)-
17-Oxoandrostan-3-yl formate
This compound is available in the following databases:
Mass Spectra of Designer Drugs 2024
Author: Peter Rösner
This library enables fast and reliable identification of the latest illegal designer drugs. It is updated annually. Learn more.